<html>
<head>PUBMED IDs for DFNX2</head>
<body bgcolor='#C5F0F2'><h1>DFNX2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23400403/'>Audiological and surgical evidence for the presence of a third window effect for the conductive hearing loss in DFNX2 deafness irrespective of types of mutations.</a> October 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23400395/'>Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension.</a> June 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23606368/'>Cytoplasmic mislocalization of POU3F4 due to novel mutations leads to deafness in humans and mice.</a> January 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24096866/'>X-linked deafness-2 (DFNX2) phenotype associated with a paracentric inversion upstream of POU3F4.</a> July 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/27863625/'>Facial nerve stimulation following cochlear implantation for X-linked stapes gusher syndrome leading to identification of a novel POU3F4 mutation.</a> March 24  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27941975/'>Novel and De Novo Mutations Extend Association of POU3F4 with Distinct Clinical and Radiological Phenotype of Hearing Loss.</a> December 13  2016<br></body></html>
